MKI67 and invasive ductal breast carcinoma: Most patients had stage IV disease (859, 80.13%), invasive ductal carcinoma (667, 62.22%), endocrine sensitivity (409, 38.15%) and a Ki-67 index >20% (640, 59.70%).